Zobrazeno 1 - 10
of 258
pro vyhledávání: ''
Autor:
Marine Perriguey, Jan-Patrick Stellmann, Adil Maarouf, Pierre Durozard, Sarah Demortiere, Jean Pelletier, Audrey Rico, Clemence Boutiere, Bertrand Audoin
Publikováno v:
Neurology Neuroimmunology & Neuroinflammation
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology Neuroimmunology & Neuroinflammation, 2021, 9 (1), pp.e1115. ⟨10.1212/NXI.0000000000001115⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Background and ObjectivesTo determine the frequency of hypogammaglobulinemia and infections in patients with multiple sclerosis (PwMS) receiving rituximab (RTX).MethodsThis prospective observational study included all consecutive PwMS receiving RTX a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a83941d2bcccd9d9a49e71db9a3b358
https://amu.hal.science/hal-03537471
https://amu.hal.science/hal-03537471
Publikováno v:
Fundamental & Clinical Pharmacology
Fundamental & Clinical Pharmacology, Wiley, 2021, 35 (4), pp.751-761. ⟨10.1111/fcp.12612⟩
Fundamental & Clinical Pharmacology, Wiley, 2021, 35 (4), pp.751-761. ⟨10.1111/fcp.12612⟩
Doctor shopping enables subjects to receive more than the prescribed dose out of any medical management, which suggests a search for high doses and makes doctor shopping a relevant proxy for misuse and potential abuse. Therefore, this study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cde0249a75e7aa0a594011d7affeb87
https://hal.archives-ouvertes.fr/hal-03620648
https://hal.archives-ouvertes.fr/hal-03620648
Autor:
S. Guillo, Florence Tubach, Massoud Toussi, Frank Andersohn, Kavitha Kuppan, Elin Heldbo Reines, Jennifer S. Haas, Jonathan Chick, K. Borchert, Sebastian Braun, Ole Lemming
Publikováno v:
Alcohol and Alcoholism
Alcohol and Alcoholism, Oxford University Press (OUP), 2021, pp.agab045. ⟨10.1093/alcalc/agab045⟩
Alcohol and Alcoholism (Oxford, Oxfordshire)
Alcohol and Alcoholism, Oxford University Press (OUP), 2021, pp.agab045. ⟨10.1093/alcalc/agab045⟩
Alcohol and Alcoholism (Oxford, Oxfordshire)
Aims Two post-authorisation studies assessed the safety and persistence of patients’ use of nalmefene. Methods The START study (EUPAS5678) was a non-interventional, multi-country, prospective, 18-month (8 follow-up visits) cohort study including ou
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2b7ed5183c7931595406abec95d319b9
https://hal.sorbonne-universite.fr/hal-03277220
https://hal.sorbonne-universite.fr/hal-03277220
Autor:
Martine Escoffre-Barbe, P. Rousselot, Pascale Cony-Makhoul, Stéphane Bouchet, Lambert Busque, Caroline Dartigeas, Franck E. Nicolini, Valérie Coiteux, Françoise Huguet, Laurence Legros, Lydia Roy, Delphine Rea, François Guilhot, Joelle Guilhot, Emilie Cayssials, Francois-Xavier Mahon, Luigina Mollica, Agnès Guerci, Martine Gardembas, Jean-Michel Cayuela, Anne Bergeron, Gabriel Etienne, Viviane Dubruille, Aude Charbonnier, Mathieu Molimard
Publikováno v:
British Journal of Haematology
British Journal of Haematology, Wiley, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, Wiley, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
British Journal of Haematology, 2021, 194 (2), pp.393-402. ⟨10.1111/bjh.17654⟩
International audience; Dasatinib is a second-generation BCR-ABL1 tyrosine kinase inhibitor approved for patients with chronic myeloid leukaemia (CML). Dasatinib 100 mg per day is associated with an increased risk of pleural effusion (PlEff). We rand
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccf07937e7bb76172bb58c0cabbf6bd0
https://hal.archives-ouvertes.fr/hal-03324903
https://hal.archives-ouvertes.fr/hal-03324903
Autor:
Yassir Aarab, Severin Ramin, Audrey Boissin, Pierre-François Perrigault, Thomas Odonnat, Philippe Cuvillon, Océane Garnier, Grégory Marin, Nicolas Molinari, Gerald Chanques
Publikováno v:
Anesthesiology
Anesthesiology, Lippincott, Williams & Wilkins, 2021, ⟨10.1097/ALN.0000000000003855⟩
Anesthesiology, Lippincott, Williams & Wilkins, 2021, ⟨10.1097/ALN.0000000000003855⟩
Background Pectoral nerve blocks have been proposed for analgesia during and after breast cancer surgery, but data are conflicted in aesthetic breast surgery. This trial tested the primary hypothesis that adding a preincisional pectoral nerve block i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ccba61f60dede3fe19a2b8c06144fe74
https://hal.archives-ouvertes.fr/hal-03276732/document
https://hal.archives-ouvertes.fr/hal-03276732/document
Autor:
Véronique Frémeaux-Bacchi, Christiane Mousson, Emma Allain Launay, David Ribes, François Provôt, Simon Ville, Aurélie Le Thuaut, Claire Presne, Anne-Laure Sellier-Leclerc, Aurélie Hummel, Ferielle Louillet, Leila Tricot, Marc Fila, Quentin Raimbourg, Stéphane Bally, Fadi Fakhouri, Eric Rondeau, Ariane Zaloszyc, Moglie Le Quintrec, Djamal Djeddi, William Hanf, Guillaume Favre, Annie Lahoche, Valérie Châtelet, Sophie Caillard, Chantal Loirat, Jean-Philippe Coindre, Claire Pouteil-Noble, Yahsou Delmas, Olivia Boyer
Publikováno v:
Blood
Blood, American Society of Hematology, 2021, 137 (18), pp.2438-2449. ⟨10.1182/blood.2020009280⟩
Blood, American Society of Hematology, 2021, 137 (18), pp.2438-2449. ⟨10.1182/blood.2020009280⟩
The optimal duration of eculizumab treatment in patients with atypical hemolytic uremic syndrome (aHUS) remains poorly defined. We conducted a prospective national multicenter open-label study to assess eculizumab discontinuation in children and adul
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::105ee1348fd54e8d802db81dde74df0a
https://hal.umontpellier.fr/hal-03222627
https://hal.umontpellier.fr/hal-03222627
Autor:
Severine Vermeire, Valérie Laurent, Anthony Buisson, Guy Lambrecht, Edouard Louis, Céline Savoye-Collet, Hedia Brixi, Sylvie Chevret, Laurent Peyrin-Biroulet, Filip Baert, Marieke Pierik, Jordi Rimola, Matthieu Allez, Philippe Van Hootegem, Philip Caenepeel, Alexandre Aubourg, Jérôme Filippi, Benjamin Pariente, Magaly Zappa, Jacques Moreau, Peter Bossuyt, Geert R. D'Haens, Yoram Bouhnik, Janneke van der Woude, David Laharie, Martine De Vos, Ragna Vanslembrouck, Yves De Bruecker, Sofie Devuysere, Denis Franchimont, Fazia Mana, Bas Oldenburg, Erwin Dreesen
Publikováno v:
Clinical Gastroenterology and Hepatology
Clinical Gastroenterology and Hepatology, WB Saunders, 2021, 19 (5), pp.947-954 e2. ⟨10.1016/j.cgh.2020.04.052⟩
Clinical gastroenterology and hepatology, 19(5), 947-954.e2. W.B. Saunders Ltd
Clinical Gastroenterology and Hepatology, WB Saunders, 2021, 19 (5), pp.947-954 e2. ⟨10.1016/j.cgh.2020.04.052⟩
Clinical gastroenterology and hepatology, 19(5), 947-954.e2. W.B. Saunders Ltd
BACKGROUND & AIMS: Higher infliximab trough levels are associated with clinical and endoscopic remission in patients with Crohn's disease (CD). We investigated pharmacodynamic features of infliximab and radiological healing. METHODS: We performed a s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::080dd656e902ff49d63e1aa7f2dacfb7
https://hal.archives-ouvertes.fr/hal-02922620
https://hal.archives-ouvertes.fr/hal-02922620
Autor:
Sarah Demortiere, Jean Pelletier, Romain Marignier, Alexandre Avouac, Bertrand Audoin, Audrey Rico, Clemence Boutiere, Adil Maarouf, Jan-Patrick Stellmann
Publikováno v:
Neurology-Neuroimmunology Neuroinflammation
Neurology-Neuroimmunology Neuroinflammation, 2021, 8, ⟨10.1212/nxi.0000000000000977⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
Neurology-Neuroimmunology Neuroinflammation, 2021, 8, ⟨10.1212/nxi.0000000000000977⟩
Neurology® Neuroimmunology & Neuroinflammation
article-version (Version of Record) 3
ObjectiveTo determine the potential association between infections and rituximab (RTX)-induced hypogammaglobulinemia among patients with CNS inflammatory diseases.MethodsWe included in a prospective observational study all consecutive adults with aqu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3f6fe7c84e76a145fff3faefe42ea3cb
https://hal.archives-ouvertes.fr/hal-03186457
https://hal.archives-ouvertes.fr/hal-03186457
Autor:
Sandrine Mansard, Philippe Saiag, Hervé Maillard, Amine Denden, Caroline Robert, Laurent Mortier, S. Dalac-Rat, Charlée Nardin, Olivier Dereure, Thierry Lesimple, Laurent Machet, Eve-Marie Neidhardt, Florent Grange, Alexandra Szenik, Caroline Dutriaux, Christophe Bedane, Céleste Lebbé, Jean-Jacques Grob
Publikováno v:
European Journal of Cancer
European Journal of Cancer, 2021, 154, pp.57-65. ⟨10.1016/j.ejca.2021.05.031⟩
European Journal of Cancer, Elsevier, 2021, 154, pp.57-65. ⟨10.1016/j.ejca.2021.05.031⟩
European Journal of Cancer, 2021, 154, pp.57-65. ⟨10.1016/j.ejca.2021.05.031⟩
European Journal of Cancer, Elsevier, 2021, 154, pp.57-65. ⟨10.1016/j.ejca.2021.05.031⟩
International audience; Background: BRAF and MEK inhibitors combination, including dabrafenib (D) and trametinib (T) have transformed the treatment of BRAF V600-mutant advanced melanoma patients, including patients with brain metastasis (BM). In a la
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7270e6beefeb71081cde6deee2aa0af2
https://hal.science/hal-03401780
https://hal.science/hal-03401780
Autor:
Pauline Jouet, Laurent Beaugerie, Anne-Laure Pelletier, Robert Benamouzig, Xavier Amiot, Nicolas Petitdidier, Georgia Malamut, Vered Abitbol, Xavier Treton, Aurelien Amiot, Lysiane Marthey, Matthieu Allez, Franck Carbonnel, Yoram Bouhnik, Sylvie Rajca, Anne Bourrier
Publikováno v:
Clinics and Research in Hepatology and Gastroenterology
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.609-618. ⟨10.1016/j.clinre.2019.11.008⟩
Clinics and Research in Hepatology and Gastroenterology, Elsevier, 2020, 44, pp.609-618. ⟨10.1016/j.clinre.2019.11.008⟩
Summary Background Whether therapeutic drug monitoring (TDM) of infliximab should be implemented in daily practice is an ongoing controversy. Aims To assess the real-world use of TDM in an observational multicentre cohort study with consecutive patie
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e77bb487b92f360087208613e087c9e8
https://hal.archives-ouvertes.fr/hal-03492351
https://hal.archives-ouvertes.fr/hal-03492351